Phase II study: second round of European funding

Phase II study: second round of European funding

As planned, VCC Medical had submitted the application in the second round of funding scheduled for the end of October as part of the “Horizon 2020” program. However, the European Commission recently requested a further update of the submission documents,...
Increased sales of AHIT® and urexent®

Increased sales of AHIT® and urexent®

For AHIT® and urexent®, FBM-PHARMA has been able to increase its sales revenues in recent months due to targeted addressing of already active medical doctors. Furthermore, new medical practices have been added, which are currently receiving intensive support from...